From Astemizole to a Novel Hit Series of Small-Molecule Somatostatin 5 Receptor Antagonists via GPCR Affinity Profiling-Reference-Cited by-同舟云学术

From Astemizole to a Novel Hit Series of Small-Molecule Somatostatin 5 Receptor Antagonists via GPCR Affinity Profiling

Published:2007-11-19 Issue:25 Volume:50 Page:6295-6298
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Guba Wolfgang¹,Green Luke G.¹,Martin Rainer E.¹,Roche Olivier¹,Kratochwil Nicole¹,Mauser Harald¹,Bissantz Caterina¹,Christ Andreas¹,Stahl Martin¹

Affiliation:

1. Discovery Chemistry, Lead Generation, F. Hoffman-LaRoche Ltd., 4070 Basel, Switzerland, Discovery Chemistry, Cheminformatics and Molecular Modeling, F. Hoffman-LaRoche Ltd., 4070 Basel, Switzerland, and Discovery, Metabolic and Vascular Diseases, F. Hoffmann-La Roche, Ltd., 4070 Basel, Switzerland

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm701144e

Reference25 articles.

1. See: http://www.vpharm.com.

2. Chemogenomic approaches to drug discovery

3. A Novel Chemogenomics Knowledge-Based Ligand Design Strategy—Application to G Protein-Coupled Receptors

4. Chemogenomics in Drug Discovery

5. Chemogenomics

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional POM-catalyst for selective oxidative dehydrogenative couplings under aerobic conditions;Molecular Catalysis;2021-02

2. A Tandem Aerobic Photocatalytic Synthesis of Benzimidazoles by Cobalt Ascorbic Acid Complex Coated on TiO2 Nanoparticles Under Visible Light;Catalysis Letters;2017-11-10

3. Pharmacological relationships and ligand discovery of G protein-coupled receptors revealed by simultaneous ligand and receptor clustering;Journal of Molecular Graphics and Modelling;2017-09

4. Discovery of novel 5-oxa-2,6-diazaspiro[3.4]oct-6-ene derivatives as potent, selective, and orally available somatostatin receptor subtype 5 (SSTR5) antagonists for treatment of type 2 diabetes mellitus;Bioorganic & Medicinal Chemistry;2017-08

5. Discovery of novel somatostatin receptor subtype 5 (SSTR5) antagonists: Pharmacological studies and design to improve pharmacokinetic profiles and human Ether-a-go-go-related gene (hERG) inhibition;Bioorganic & Medicinal Chemistry;2017-08